Clinical trial / 2014
Korean red ginseng and its ginsenoside extract acutely improved flow-mediated vasodilatation in healthy adults without altering brachial blood pressure.
In a double-blind crossover study, 16 healthy participants were administered 3 g Korean red ginseng (KRG) root, KRG ginsenosides extract, KRG polysaccharides extract, or cornstarch control on four separate occasions. FMD was assessed at baseline, 90 min, and 180 min posttreatment. KRG significantly improved FMD with a maximal vasodilatation of Δ2.57 ± 2.8% at 180 min versus control (Δ-0.83 ± 2.7%, P = 0.003). The ginsenoside extract produced a comparable response (Δ1.75 ± 2.6%), while the polysaccharide fraction did not (Δ0.10 ± 2.7%), and brachial blood pressure remained unchanged across treatments (P = 0.45).
- Study type
- Acute randomized, placebo-controlled, double-blind crossover trial
- Who was studied
- 16 healthy participants (9 men, 7 women, age 30 ± 9 years, BMI 24 ± 3 kg/m²)
- What was measured
- Flow-mediated vasodilatation (FMD) and brachial blood pressure
THE PAPER
Modulation of endothelial function by Korean red ginseng (Panax ginseng C.A. Meyer) and its components in healthy individuals: a randomized controlled trial.
Jovanovski E, Peeva V, Sievenpiper JL, Jenkins AL, Desouza L, Rahelic D, Sung MK, Vuksan V. Cardiovasc Ther, 2014.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.